<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02721628</url>
  </required_header>
  <id_info>
    <org_study_id>zoc-ekccl2015</org_study_id>
    <nct_id>NCT02721628</nct_id>
  </id_info>
  <brief_title>Epi-keratoplasty Versus Collagen Cross-Linking in Progressive Keratoconus</brief_title>
  <official_title>Femtosecond Laser Assisted Epi-keratoplasty Versus Collagen Cross-Linking in Progressive Keratoconus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Epi-keratoplasty Versus Collagen Cross-Linking in Progressive Keratoconus
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Keratoconus is a bilateral corneal ecstatic disease which is not uncommon and always behaves
      progressively and results in visual impairment by inducing irregular astigmatism and corneal
      opacities.

      Collagen Cross-Linking (CXL) is widely used in progressive keratoconus. The cornea is soaked
      with a riboflavin solution and then being exposed to ultraviolet-A radiation. The performance
      creates links between collagen fibrils in order to rigidify the corneal stroma and slow down
      the progression of keratoconus. However, the effectiveness is not satisfied and accompanied
      with risks of side effects and serious complications, such as pain for the first two
      post-operative days, temporary loss of visual acuity during the first three months, infection
      and stromal opacity due to corneal scarring.

      Epi-keratoplasty is a reversible technique in which a corneal graft is transplanted on the
      recipients' eye with only removal of the epithelium of the receptor cornea. The procedure was
      assisted by femtosecond laser which allows precisely and neatly cutting. The graft strengths
      the whole host corneal rigidity and roughness and therefore renders the progression of
      keratoconus.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes of Spherical equivalent</measure>
    <time_frame>01012016~01012018: preoperatively, postoperatively 2 weeks, 1,2,3,6,12 months, 2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>maximum keratometry (K-max) derived from computerized video keratography</measure>
    <time_frame>01012016~01012018: preoperatively, postoperatively 2 weeks, 1,2,3,6,12 months, 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>minimum keratometry</measure>
    <time_frame>01012016~01012018: preoperatively, postoperatively 2 weeks, 1,2,3,6,12 months, 2 years</time_frame>
    <description>also from computerized video keratography, the opposite description of K-max</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>01012016~01012018: preoperatively, postoperatively 2 weeks, 1,2,3,6,12 months, 2 years</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Spherical equivalent</measure>
    <time_frame>01012016~01012018: preoperatively, postoperatively 2 weeks, 1,2,3,6,12 months, 2 years</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Progressive Keratoconus</condition>
  <arm_group>
    <arm_group_label>Epi-keratoplasty Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Epi-keratoplasty Group: Reversible keratoplasty performed with only the removal of corneal epithelium of the host cornea. A donor graft is transplanted on the recipients' eye locating on the Bowman's layer.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Collagen Cross-Linking Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Collagen Cross-Linking: Corneal epithelium is mechanically removed. Then, a solution of riboflavin is instilled each minute for 30 minutes. Corneas are irradiated by a UVA light for 3mW/cm2 during 30 minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Epi-keratoplasty</intervention_name>
    <description>Femtosecond laser assisted Epi-keratoplasty</description>
    <arm_group_label>Epi-keratoplasty Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Collagen Cross-Linking</intervention_name>
    <description>Collagen Cross-Linking: Standard procedure, which is descriptor bellows: Corneal epithelium is mechanically removed. Then, a solution of riboflavin is instilled each minute for 30 minutes. Corneas are irradiated by a UVA light for 3mW/cm2 during 30 minutes</description>
    <arm_group_label>Collagen Cross-Linking Group</arm_group_label>
    <other_name>CCL</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Femtosecond laser</intervention_name>
    <description>Use in the epic-keratoplasty surgery</description>
    <arm_group_label>Epi-keratoplasty Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis of Keratoconus

          -  Age ≥ 18 years old

          -  Corneal thickness ≥ 400 µm

          -  Progressive stage 1 to 3 keratoconus (Krumeich classification)

        Exclusion Criteria:

          -  Corneal thickness &lt; 400µm

          -  Concomitant corneal disease

          -  History of corneal surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Xinbo Gao, MD, PHD</last_name>
    <phone>+8613570942794</phone>
    <email>ice.freeport@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>ZhongShan Ophthalmic Center</name>
      <address>
        <city>GuangZhou</city>
        <state>Guangdong</state>
        <zip>510060</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gao Xinbo, MD</last_name>
      <email>ice.freeport@163.com</email>
    </contact>
    <investigator>
      <last_name>Gao Xinbo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 6, 2016</study_first_submitted>
  <study_first_submitted_qc>March 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 29, 2016</study_first_posted>
  <last_update_submitted>March 22, 2016</last_update_submitted>
  <last_update_submitted_qc>March 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Gao Xinbo</investigator_full_name>
    <investigator_title>Attendant Doctor</investigator_title>
  </responsible_party>
  <keyword>Keratoconus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>undecided</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

